Randomized, double blind, placebo controlled trial to compare the efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephritic syndrome

被引：0
|
作者：
Sinha, Aditi [1 ]
Bagga, Arvind [1 ]
Sharma, Sonia [1 ]
Saha, Abhijeet [2 ]
Kumar, Manish [3 ]
Afzal, Kamran [4 ]
Mehta, Amarjeet [5 ]
Hari, Pankaj [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
[2] Dr Ram Manohar Lohia Hosp, New Delhi, India
[3] Chacha Nehru Bal Chikitsalya, Delhi, India
[4] Jawaharlal Nehru Med Coll, Aligarh, Uttar Pradesh, India
[5] Sawai Man Singh Med Coll, Jaipur, Rajasthan, India
来源：
PEDIATRIC NEPHROLOGY | 2013年 / 28卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：1361 / 1362
页数：2
相关论文
共 50 条
  • [1] RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL TO COMPARE THE EFFICACY OF 3-MONTHS VERSUS 6-MONTHS THERAPY WITH PREDNISOLONE FOR THE FIRST EPISODE OF IDIOPATHIC NEPHROTIC SYNDROME [CTRI/2010/091/001095]
    Bagga, Arvind
    Sinha, Aditi
    Saha, Abhijeet
    Kumar, Manish
    Afzal, Kamran
    Mehta, Amarjeet
    Hari, Pankaj
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1707 - 1707
  • [2] Randomized controlled trial to compare efficacy of 3-months versus 6-months therapy with prednisolone for the first episode of idiopathic nephrotic syndrome in children <4-yr-old
    Sinha, A.
    Hari, P.
    Bagga, A.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1867 - 1868
  • [3] Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
    S. Bo
    V. Ponzo
    A. Evangelista
    G. Ciccone
    I. Goitre
    F. Saba
    M. Procopio
    M. Cassader
    R. Gambino
    Acta Diabetologica, 2017, 54 : 499 - 507
  • [4] Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial
    Bo, S.
    Ponzo, V.
    Evangelista, A.
    Ciccone, G.
    Goitre, I.
    Saba, F.
    Procopio, M.
    Cassader, M.
    Gambino, R.
    ACTA DIABETOLOGICA, 2017, 54 (05) : 499 - 507
  • [5] Telemetrically triggered interventions in the first month of CPAP: 6-months results of a prospective, randomized controlled trial
    Schoch, O. D.
    Baty, F.
    Benz, G.
    Niedermann, J.
    Brutsche, M. H.
    CHEST, 2017, 151 (05) : 10A - 11A
  • [6] PREVENTION OF RELAPSES WITH LEVAMISOLE AS ADJUVANT THERAPY TO CORTICOSTEROIDS IN CHILDREN WITH A FIRST EPISODE OF IDIOPATHIC NEPHROTIC SYNDROME - AN INTERNATIONAL, DOUBLE-BLIND, PLACEBO-CONTROLLED RANDOMIZED TRIAL.
    Floor, Veltkamp
    Christa, Reefman
    Djera, Khan H.
    Susan, Veissi
    Lotte, Haverman
    Aa, Mathot Ron
    Elena, Levtchenko
    Michiel, Schreuder F.
    Ae, Van Wijk Ans
    Sandrine, Florquin
    Hm, Bouts Antonia
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1938 - 1938
  • [7] PROSPECTIVE RANDOMIZED DOUBLE-BLIND TRIAL OF 3 VERSUS 6 MONTHS OF NAFARELIN THERAPY FOR ENDOMETRIOSIS-ASSOCIATED PELVIC PAIN
    HORNSTEIN, MD
    YUZPE, AA
    BURRY, KA
    HEINRICHS, LR
    BUTTRAM, VL
    ORWOLL, ES
    FERTILITY AND STERILITY, 1995, 63 (05) : 955 - 962
  • [8] Rotigotine transdermal patch is effective in the treatment of idiopathic RLS: Results of a 6 months, multicentre, double blind, placebo controlled trial in Europe
    Oertel, W. H.
    Benes, H.
    Chaudhuri, R.
    Ferini-Strambi, L.
    Hoegl, B.
    Garcia-Borreguero, D.
    Keffel, J.
    Kohnen, R.
    Montagna, P.
    Partinen, M.
    Poewe, W.
    Schollmayer, E.
    Stiasny-Kolster, K.
    Trenkwalder, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 13 - 13
  • [9] Cessation versus Continuation of Galantamine Treatment after 12 Months of Therapy in Patients with Alzheimer's Disease: A Randomized, Double Blind, Placebo Controlled Withdrawal Trial
    Scarpini, Elio
    Bruno, Giuseppe
    Zappala, Giuseppe
    Adami, Marina
    Richarz, Ute
    Gaudig, Maren
    Jacobs, Adam
    Schaeuble, Barbara
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (02) : 211 - 220
  • [10] Prolongation of oral anticoagulant treatment for eighteen months versus placebo at the decline of a first episode of idiopathic pulmonary embolism treated for six months: A randomised, multicentric, double blind trial. 2006 National PHRC (Hospital clinical research programme): "PADIS-EP/Prolongation of anticoagulant treatment for 18 months for a first episode of PE initially treated for 6 months"
    Couturaud, F.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2008, 64 (06) : 332 - 336
12345